All stock reports

NATCOPHARM evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-23T23:41:24.758489+00:00

Metrics

latest_annual_period
2026-03-31
revenue
40783000000.0
net_income
14185000000.0
operating_cash_flow
17683000000.0
free_cash_flow
13772000000.0
total_assets
110737000000.0
total_liabilities
18526000000.0
total_equity
92211000000.0
cash
15509000000.0
total_debt
7139000000.0
revenue_growth
-0.0797851937092443
earnings_growth
-0.2476397581415084
net_margin
0.3478164921658534
roe
0.1538319723243431
debt_to_equity
0.07742026439361899
cash_conversion
1.2465985195629186
free_cash_flow_margin
0.3376897236593679
trailing_pe
11.7435
forward_pe
16.8634
peg_ratio
Not supplied
price_to_book
1.818
dividend_yield
0.0053

Other positional research

No qualifying opportunity

No candidate at another positional horizon in the coherent source run.

  • No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
Decision ID
decision-4b27cc51af3c70a826230866606f00a520d5a98c0bbef70be5101a851dbabedf
Policy
stock-decisions-v1
Evidence bundle hash
a45cb9e7e2df1ee38bf388cbf1db012ab089f7e27fee23e505e2ef6ba842bae2
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 4112b776608103ad4be89a0bdd83a17770a1cba86c92ffffb4e97deb39508f5a
  • daily-price: 66069636a2aedd1991c515836cae31e30ed3d3fa41c93040f6ea149ae9502cd7
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The cached closing price on 2026-10-01 was INR 821.30. The trailing 5-session price return was -2.46%. The trailing 20-session price return was -2.60%. The trailing 60-session price return was -14.86%. The trailing 250-session price return was -1.98%.

Risks

Average cached traded value over twenty sessions was INR 377,829,528. The closing price was -31.78% below its highest close in the available trailing year. The cached financial metric revenue growth is -0.0797851937092443. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

The cached financial metric latest annual period is 2026-03-31. The cached financial metric net margin is 0.3478164921658534. The cached financial metric roe is 0.1538319723243431. The cached financial metric debt to equity is 0.07742026439361899. The cached financial metric cash conversion is 1.2465985195629186. The cached financial metric free cash flow margin is 0.3376897236593679.

Cached observations and evidence limits